Hematica
Hematica provides standardized methods to assess the performance and usability of biomedical devices in simulated clinical settings, delivering clear and rapid results for hemodialysis optimization. The company is developing a Real-Time Dialysis Therapy Monitoring device that empowers clinicians with data-driven therapy personalization, supported by a track record of scientific publications.
- Healthcare Technology
- Medical Devices
- Hardware
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Hemodialysis treatments require precise monitoring and optimization to ensure patient safety and treatment efficacy, yet current methods for assessing device performance and usability often lack standardization. Clinicians face challenges in evaluating biomedical devices under realistic conditions, which can lead to suboptimal therapy personalization and delayed identification of device issues.
Solution
Hematica offers straightforward, standardized methods to assess the performance and usability of biomedical devices in simulated clinical settings, delivering clear and rapid results. The company is developing a Real-Time Dialysis Therapy Monitoring device that empowers clinicians with data-driven therapy personalization. This technology enables healthcare providers to evaluate device efficiency and safety systematically, supporting evidence-based decisions for optimizing hemodialysis treatments. By combining standardized assessment protocols with advanced monitoring capabilities, Hematica bridges the gap between device evaluation and clinical application.
Target Audience
Primary customers are nephrology clinics, dialysis centers, and biomedical device manufacturers seeking standardized evaluation methods and real-time monitoring solutions for hemodialysis treatments.
Features
- Standardized assessment protocols for evaluating biomedical device performance and usability in simulated clinical environments
- Real-Time Dialysis Therapy Monitoring device currently under development for continuous treatment oversight
- Data-driven therapy personalization tools that support clinician decision-making
- Clear, rapid result delivery for efficient device evaluation workflows
- Scientific publication track record supporting evidence-based methodology development, including research on sampling from extracorporeal circuits